Articles by Piero Ruggenenti : Journal of the American Society of Nephrology

Journal Logo

Articles by Piero Ruggenenti

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

Ruggenenti, Piero; Debiec, Hanna; Ruggiero, Barbara; More

Journal of the American Society of Nephrology. 26(10):2545-2558, October 2015.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

Schanstra, Joost P.; Zürbig, Petra; Alkhalaf, Alaa; More

Journal of the American Society of Nephrology. 26(8):1999-2010, August 2015.

Paricalcitol for Secondary Hyperparathyroidism in Renal Transplantation

Trillini, Matias; Cortinovis, Monica; Ruggenenti, Piero; More

Journal of the American Society of Nephrology. 26(5):1205-1214, May 2015.

Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome

Ruggenenti, Piero; Ruggiero, Barbara; Cravedi, Paolo; More

Journal of the American Society of Nephrology. 25(4):850-863, April 2014.

Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes

Ruggenenti, Piero; Porrini, Esteban; Motterlini, Nicola; More

Journal of the American Society of Nephrology. 23(10):1717-1724, October 2012.

Sirolimus Therapy to Halt the Progression of ADPKD

Perico, Norberto; Antiga, Luca; Caroli, Anna; More

Journal of the American Society of Nephrology. 21(6):1031-1040, June 2010.

ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome

Cattaneo, Dario; Ruggenenti, Piero; Baldelli, Sara; More

Journal of the American Society of Nephrology. 20(6):1404-1415, June 2009.

Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal Transplantation: The MYSS Follow-Up Randomized, Controlled Clinical Trial

Remuzzi, Giuseppe; Cravedi, Paolo; Costantini, Marco; More

Journal of the American Society of Nephrology. 18(6):1973-1985, June 2007.

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial

Ruggenenti, Piero; Perna, Annalisa; Ganeva, Maria; More

Journal of the American Society of Nephrology. 17(12):3472-3481, December 2006.

Continuum of Renoprotection with Losartan at All Stages of Type 2 Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL Trial Results

Remuzzi, Giuseppe; Ruggenenti, Piero; Perna, Annalisa; More

Journal of the American Society of Nephrology. 15(12):3117-3125, December 2004.

Chronic Proteinuric Nephropathies. II. Outcomes and Response to Treatment in a Prospective Cohort of 352 Patients: Differences Between Women and Men in Relation to the ACE Gene Polymorphism

RUGGENENTI, PIERO; PERNA, ANNALISA; ZOCCALI, CARMINE; More

Journal of the American Society of Nephrology. 11(1):88-96, January 2000.

In Chronic Nephropathies Prolonged ACE Inhibition Can Induce Remission: Dynamics of Time-Dependent Changes in GFR

RUGGENENTI, PIERO; PERNA, ANNALISA; BENINI, ROBERTO; More

Journal of the American Society of Nephrology. 10(5):997-1006, May 1999.

Hypocomplementemia Discloses Genetic Predisposition to Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: Role of Factor H Abnormalities

NORIS, MARINA; RUGGENENTI, PIERO; PERNA, ANNALISA; More

Journal of the American Society of Nephrology. 10(2):281-293, February 1999.

Show: